CoViD-19 Patient in Reims University Hospital in March to April 2020
- Conditions
- Coronavirus Infections
- Interventions
- Biological: serology
- Registration Number
- NCT04553575
- Lead Sponsor
- CHU de Reims
- Brief Summary
Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up.
Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research)
Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients.
Material and methods:
Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022
Expected results: Better knowledge of the cares of patients with CoViD-19
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 127
- Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort
- Age > 18 years
- Patient who benefit from the national health insurance coverage
- patient agree for participation (consent form signed)
- Patient protected by law
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CoViD-19 patients cohort serology Patients are followed for 2 years after diagnosis. The only one intervention is blood samples withdrawn for serologies
- Primary Outcome Measures
Name Time Method Health status in the 2 years after CoViD-19 diagnosis 2 years follow up status : dead or alive persistante respiratory distress (yes / no)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Reims
🇫🇷Reims, France